Literature DB >> 17173363

Comparison of the performance of chiral stationary phase for separation of fluoxetine enantiomers.

Jie Zhou1, Yi-wen Yang, Feng Wei, Ping-dong Wu.   

Abstract

Separation of fluoxetine enantiomers on five chiral stationary phases (chiralcel OD-H, chiralcel OJ-H, chiralpak AD-H, cyclobond capital I, Ukrainian 2000 DM and kromasil CHI-TBB) was investigated. The optimal mobile phase compositions of fluoxetine separation on each column were hexane/isopropanol/diethyl amine (98/2/0.2, v/v/v), hexane/isopropanol/diethyl amine (99/1/0.1, v/v/v), hexane/isopropanol/diethyl amine (98/2/0.2, v/v/v), methanol/0.2% triethylamine acetic acid (TEAA) (25/75, v/v; pH 3.8) and hexane/isopropanol/diethyl amine (98/2/0.2, v/v/v), respectively. Experimental results demonstrated that baseline separation (R(S)>1.5) of fluoxetine enantiomers was obtained on chiralcel OD-H, chiralpak AD-H, and cyclobond capital I, Ukrainian 2000 DM while the best separation was obtained on the last one. The eluate orders of fluoxetine enantiomers on the columns were determined. The first eluate by chiralcel OJ-H and kromasil CHI-TBB is the S-enantiomer, while by chiralpak AD-H and cyclobond I 2000 DM is the R-enantiomer.

Entities:  

Year:  2007        PMID: 17173363      PMCID: PMC1764917          DOI: 10.1631/jzus.2007.B0056

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  11 in total

1.  Intellectual property and chirality of drugs.

Authors: 
Journal:  Drug Discov Today       Date:  1999-07       Impact factor: 7.851

2.  High-throughput chiral liquid chromatography/tandem mass spectrometry.

Authors:  R Bakhtiar; F L Tse
Journal:  Rapid Commun Mass Spectrom       Date:  2000       Impact factor: 2.419

3.  Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry.

Authors:  C B Eap; N Gaillard; K Powell; P Baumann
Journal:  J Chromatogr B Biomed Appl       Date:  1996-07-12

4.  Fluorometric determination of DL-fenfluramine, DL-norfenfluramine and phentermine in plasma by achiral and chiral high-performance liquid chromatography.

Authors:  A Kaddoumi; M N Nakashima; K Nakashima
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-11-05

5.  Cyclodextrin chiral stationary phases for liquid chromatographic separations of drug stereoisomers.

Authors:  A Berthod; H L Jin; T E Beesley; J D Duncan; D W Armstrong
Journal:  J Pharm Biomed Anal       Date:  1990       Impact factor: 3.935

6.  Chiral high-performance liquid chromatographic analysis of fluoxetine and norfluoxetine in rabbit plasma, urine, and vitreous humor using an acetylated beta-cyclodextrin column.

Authors:  L Yee; S H Wong; V A Skrinska
Journal:  J Anal Toxicol       Date:  2000-10       Impact factor: 3.367

7.  Enantiomeric separation and quantification of fluoxetine (Prozac) in human plasma by liquid chromatography/tandem mass spectrometry using liquid-liquid extraction in 96-well plate format.

Authors:  Zhongzhou Shen; Sui Wang; Ray Bakhtiar
Journal:  Rapid Commun Mass Spectrom       Date:  2002       Impact factor: 2.419

8.  Determination of fluoxetine enantiomers in rat plasma by pre-column fluorescence derivatization and column-switching high-performance liquid chromatography.

Authors:  Xingjie Guo; Takeshi Fukushima; Famei Li; Kazuhiro Imai
Journal:  Analyst       Date:  2002-04       Impact factor: 4.616

9.  Determination of fluoxetine hydrochloride enantiomeric excess using high-performance liquid chromatography with chiral stationary phases.

Authors:  B A Olsen; D D Wirth; J S Larew
Journal:  J Pharm Biomed Anal       Date:  1998-08       Impact factor: 3.935

10.  Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography.

Authors:  Giuliana Gatti; Ilaria Bonomi; Roberto Marchiselli; Cinzia Fattore; Edoardo Spina; Gabriella Scordo; Roberta Pacifici; Emilio Perucca
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-02-05       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.